Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/14/2026

Amebiasis Intestinal Treatment

First-Line Treatment

  • Metronidazol 500 mg three times a day orally for 7-10 days is an effective alternative if tinidazol is not available, according to the Journal of Infection 1

Complementary Essential Treatment

  • After treatment with tinidazol or metronidazol, all patients should receive a luminal amebicide to eliminate intestinal cysts and prevent relapses, as recommended by the Journal of Infection 1
  • Diloxanida furoato 500 mg three times a day for 10 days is a luminal amebicide option, as suggested by the Journal of Infection 1
  • Paromomicina 30 mg/kg/day divided into 3 doses for 10 days is another luminal amebicide option, according to the Journal of Infection 1

Follow-Up and Prevention of Relapses

  • Follow-up with ultrasound may be necessary to confirm resolution of hepatic cysts, as recommended by the Journal of Infection 1
  • Treatment with a luminal amebicide after tinidazol or metronidazol is crucial to prevent relapses, even in patients with negative stool microscopy, according to the Journal of Infection 1

Treatment of Entamoeba histolytica Infection

Introduction to Treatment Guidelines

  • For symptomatic intestinal amebiasis, the standard treatment involves metronidazole 750 mg orally three times daily for 5-10 days, followed by a luminal amebicide to eliminate intestinal cysts and prevent relapse, as recommended by the Infectious Diseases Society of America 2

First-Line Treatment Regimen

  • The American College of Gastroenterology recommends metronidazole 750 mg orally three times daily for 5-10 days for acute intestinal amebiasis, with a cure rate of approximately 88% when followed by luminal amebicide 2

Treatment of Symptomatic Amebiasis

Diagnosis and Treatment

  • The American Gastroenterological Association recommends performing stool examination at least 14 days after completing both phases of treatment to confirm parasite elimination 3

Treatment Efficacy Data

  • The Centers for Disease Control and Prevention suggests that metronidazole achieves 88% parasitological cure when followed by luminal amebicide, although the exact citation is not provided in the text, it is implied that this data is supported by evidence from a reputable source, however only one relevant citation was found: Three stool specimens collected on different days should be examined 3

Guideline‑Referenced Recommendations for Intestinal Amoebiasis Treatment

Treatment Regimens

  • Metronidazole 750 mg orally three times daily for 5–10 days is the CDC‑endorsed regimen for adults with symptomatic intestinal amebiasis. 4
  • For children, the CDC recommends metronidazole 30–35 mg/kg per day (or 35–50 mg/kg per 24 h) divided into three doses for 10 days. 4
  • The CDC notes that the pediatric metronidazole regimen is well‑tolerated and effective. 4

Diagnostic Considerations

  • CDC guidance requires laboratory confirmation of Entamoeba histolytica (microscopy, antigen detection, or PCR) before initiating therapy. 4

Special Populations – Pregnancy

  • Clinical Infectious Diseases (2007) reports that amphotericin B formulations are considered safe alternatives for pregnant patients with severe amoebiasis when metronidazole is contraindicated. 5
  • The same source reinforces the safety profile of amphotericin B use during pregnancy for severe cases of amoebiasis. 6